SUMMARY The case of a middle aged woman who presented with fibrosing alveolitis, in her mid-forties, followed by a sicca syndrome and who subsequently developed a pulmonary lymphoma (B cell) while receiving azathioprine therapy is recorded. Of interest was the absence of polyclonal B cell activation, e.g., production of rheumatoid factor, hypergammaglobulinaemia, high titre antinuclear antibodies or antibodies to extractable nuclear antigens (ENA) during most of her illness. Persistently raised IgM levels and low IgA levels were demonstrated. The relevance of azathioprine to development of the lymphoma is discussed.
This 59 year old woman first became ill at the age of 33 when she complained of polyarthralgias affecting the hands, knees, and ankles. Several years later at age 44, when admitted for a hysterectomy, a routine chest x ray showed reticular shadowing at the left base. She had a positive antinuclear factor (1/40), an increase of IgG and IgM globulin fractions, and autoantibodies were negative. A presumptive diagnosis of early fibrosing alveolitis was made. The following year she complained of recurrent 'gritty' eyes and attacks of conjunctivitis, and at the age of 50, when she presented herself as a blood donor, she was found to have a positive Coombs' test and the antinuclear factor was still 1/40. In 1979 she was found to have a positive Schirmer's test, and keratoconjunctivitis sicca was diagnosed. A salivary gland biopsy showed local chronic inflammation, atrophy of gland acini, and hyperplasia of the duct epithelium confirming Sjogren's syndrome. Because Acccptcd for publication 23 March 1987. Corrcspondence to Dr R A Ashcrson. Thc Raync Institutc, St Thomas's Hospital, London SEI 7EH.
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of a raised erythrocyte sedimentation rate (ESR) of 155 m/h, a rash on the butterfly area of the face, and positive DNA binding she was thought to have systemic lupus erythematosus (SLE) in 1980, and treatment was started with systemic steroid therapy prednisolone (40 mg daily) and azathioprine (150 mg daily). The rash was diagnosed as acne rosacea and responded to tetracycline therapy. Over the next year she developed multiple drug allergies (penicillin, nitrofurantoin, sulphonamides, tetracyclines, and lincomycin), a chronic watery diarrhoea, and recurrent upper respiratory infections. Over the ensuing five years she had a persistent chronic cough and required repeated hospital admissions, three of which were to the intensive care unit for treatment of these pulmonary infections. The offending organism was usually Haemophilus influenzae, but on one occasion (in 1985) she was found to have Epstein-Barr virus in the lungs. Her ESR remained persistently raised, and she was maintained on varying doses of prednisolone and azathioprine during this period.
Dyspnoea on exertion became a problem and by 1986 her exercise tolerance was reduced to 50 yards. From 1979 onwards her chest x rays were abnormal, showing persistent reticular shadowing at the bases with right middle lobe consolidation, later progressing to patchy, ill defined shadowing throughout both lung fields (Fig. 1) .
In 1986 she was admitted to St Thomas's Hospital for evaluation and open lung biopsy. On admission she was Cushingoid, with a 'buffalo hump' and moon face. She complained of proximal weakness, dryness of the eyes and mouth, and felt generally unwell.
A mild synovitis of the small joints of both hands was present. Bilateral basal crepitations were audible, but the rest of the clinical examination was essentially normal.
I N V E S T I G A T I O N S
Investigations showed a normal haemoglobin, white cell and platelet count. Polyethylene glycol immune complexes were present to a level of 70 mg IgG/l (normal <49 mg IgG/I).
A At operation the findings were of nodular infiltration of the middle and lower lobes, the middle lobe being completely solid with hard nodules present throughout the lung parenchyma.
Microscopy of the pathological specimens showed a fairly monomorphic infiltration by lymphoid cells (Fig. 2) other histological varieties termed 'angioimmunoblastic', lymphadenopathy, and 'immunoblastic sarcoma' have also been described. This last term has been used recently to reclassify some of these neoplasms, and this type has been found to be associated with autoimmune disease in approximately 30% of cases.9 10 It appears that previous descriptions of lymphomas associated with SS and termed reticulum cell sarcoma, histocytic lymphoma, and poorly differentiated lymphocytic lymphoma will all be now reclassified as immunoblastic sarcomata.
Recurrent parotid swelling, splenomegaly, and lymphadenopathy appear to confer a high risk for the subsequent development of malignancy in patients with SS,'" and a drop in rheumatoid factor titre and IgM concentration may presage the appearance of this malignancy.' There is also some speculation as to whether this association is limited to those patients demonstrating anti-Ro antibodies. 12 Initially, isolated benign lymphoepithelial proliferation .(now termed myoepithelial sialadenitis) may occur in the salivary glands themselves, or serum autoantibodies may be present in otherwise asymptomatic patients. This situation may progress into frank SS with monoclonal immunoglobulin production and the appearance of 'pseudolymphomas'-a term used when immature, but seemingly non-malignant mononuclear cells infiltrate extraglandular tissue. The final stage occurs in a small percentage of patients when these lymphocytes undergo malignant transformation with possible accompanying hypogammaglobulinaemia and immunodeficiency. This has been likened by Talal to the relationship between benign monoclonal spikes and myeloma/macroglobulinaemia or between ARC (AIDS related complex) and AIDS (acquired immune deficiency syndrome). '3 This progression from an autoimmune process to a lymphoma may be seen in spontaneous autoimmune disease, in mice with experimentally induced chronic graft versus host disease, and in patients with rheumatoid arthritis, where a recent study showed a 2-2% incidence of lymphoproliferative malignancies developing after a mean interval of 11-8 years. '4 The lung is frequently involved in cases of generalised malignant lymphoma, and a primary tumour may be confused with, and must be differentiated from, localised inflammatory masses composed of lymphoid cells. In contrast with inflammatory masses, however, lymphomas are monomorphic and follicles with germinal centres are absent. The cells may invade the pleura, bronchi, and veins, but demonstration of monotypic neoplastic lymphoid cells by immunological marker studies confirmed the diagnosis in our patient. 
